Ezetimibe plus statin combination versus double-dose statin in patients with dyslipidemia and atherosclerotic cardiovascular disease risk: a comprehensive systematic review and meta-analysis of 47 randomized controlled trials
Sign Up to like & getrecommendations! Published in 2025 at "Baylor University Medical Center Proceedings"
DOI: 10.1080/08998280.2025.2487966
Abstract: Abstract Background Dyslipidemia is a major risk factor for atherosclerotic cardiovascular disease (ASCVD). Oral regimens to achieve blood lipid targets include increasing the statin dose or adding ezetimibe to statin therapy. The optimal strategy remains… read more here.
Keywords: dose statin; plus statin; risk; double dose ... See more keywords